تصفح حسب العنوان
الآن تُعرض المواد 113803 -- 113822 من 262872
-
N'attendons pas encore 40 ans : discussion
(1997) -
N,N-Dimethylformamide
(2001) -
n-Hexane
(1991)Evaluates the risks to human health and the environment posed by n-hexane, a chemical isolated from natural gas and crude oil and used in food processing to extract vegetable oil from beans, nuts, and seeds. n-Hexane is also used as a solvent, a cleaning agent, in the rubber industry, and in the manufacture of pharmaceuticals. The opening sections review what is known about the behaviour of this highly volatile chemical in the environment and its metabolic fate in experimental animals and in the human body. A review of investigations in experimental ... -
n-Hexane : health and safety guide
(1991) -
N-methyl-2-pyrrolidone
(2001) -
N-Nitrosodimethylamine
(2002) -
N-phenyl-1-naphthylamine
(1998) -
Nachhaltige Entwicklung und die Gesundheit: Konzepte, Grundsätze und Handlungsrahmen für europäische Städte und Gemeinden
(1997, EUR/ICP/POLC060305a) -
Naître défavorisés / Fredj Stambouli
(1990) -
Naltrexone injection site reactions
(2008) -
Namibia : Calidad de Miembro y Contribución
(1977, EB59.R44) -
Namibia: calidad de miembro y contribución, informe del Director General
(1977, EB59/41) -
Nanotechnology and human health: scientific evidence and risk governance: report of the WHO expert meeting: 10–11 December 2012, Bonn, Germany
(2013, WHO/EURO:2013-4491-44254-62511)Nanotechnology, the science and application of objects smaller than 100 nanometres, is evolving rapidly in many fields. Besides the countless beneficial applications, including in health and medicine, concerns exist on adverse health consequences of unintended human exposure to nanomaterials. In the 2010 Parma Declaration on Environment and Health, ministers of health and of environment of the 53 Member States of the WHO Regional Office for Europe listed the health implications of nanotechnology and nanoparticles among the key environment and ... -
Nanotechnology-based medicinal products
(2006)